Back
Akebia Therapeutics Vs. Bioventus Industry Stock Comparison
Buy
63
AKBA
Akebia Therapeutics
Last Price:
1.87
Seasonality Move:
44.29%
Buy
99
BVS
Bioventus
Last Price:
11.13
Seasonality Move:
-13.38%
Buy
63
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.92. The Score for AKBA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
99
Bioventus (BVS)
is a Buy
Is Bioventus a Buy, Sell or Hold?
- The current Bioventus [BVS] share price is $11.16. The Score for BVS is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- BVS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.92
The current trend is moderately bullish and AKBA is experiencing slight selling pressure.
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 66.7 | Buy |
| Chaikin Money Flow: | -753866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.39 - 1.87) | Buy |
| Bollinger Bands (100): | (1.15 - 1.63) | Buy |
BVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 40.2 | Sell |
| Chaikin Money Flow: | -338658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.7 - 13.4) | Sell |
| Bollinger Bands (100): | (7.14 - 12.16) | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.92 | Sell |
| 20-day SMA: | 1.71 | Buy |
| 50-day SMA: | 1.5 | Buy |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.89 | Buy |
| 20-day EMA: | 1.75 | Buy |
| 50-day EMA: | 1.57 | Buy |
| 200-day EMA: | 1.38 | Buy |
BVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.87 | Sell |
| 20-day SMA: | 12.67 | Sell |
| 50-day SMA: | 11.84 | Sell |
| 200-day SMA: | 7.44 | Buy |
| 8-day EMA: | 11.94 | Sell |
| 20-day EMA: | 12.24 | Sell |
| 50-day EMA: | 11.58 | Sell |
| 200-day EMA: | 8.31 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.
Bioventus Earnings Growth & BVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.25 per share.
Akebia Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bioventus Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||